Related Experiment Video
Updated: Feb 4, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
How we approach: Severe congenital neutropenia and myelofibrosis due to mutations in VPS45
Bella Shadur1,2,3, Nathalie Asherie1, Peter E Newburger4
1Bone Marrow Transplantation Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Abstract:
Mutations in the VPS45 gene lead to a severe primary immune deficiency characterized by severe congenital neutropenia and primary myelofibrosis, leading to overwhelming infection and early death. This condition is exceedingly rare with only 16 patients previously reported, including four with successful hematopoietic stem cell transplantation. We review the pathophysiology underlying this condition and detail our approach to treatment, particularly vis-à-vis bone marrow transplantation and the challenges of transplanting into a diseased bone marrow niche. We provide an update on the progress of our three previously reported patients, and two additional patients transplanted at our center.
Insights
Mutations in the VPS45 gene cause a rare immune disorder leading to severe neutropenia and myelofibrosis. Hematopoietic stem cell transplantation offers a potential treatment, though challenges remain in diseased bone marrow environments.
Area of Science:
- Immunology
- Genetics
- Hematology
Background:
- VPS45 gene mutations result in severe primary immune deficiency.
- This condition presents as congenital neutropenia and primary myelofibrosis.
- The disease leads to overwhelming infections and early mortality.
Observation:
- This rare disorder has only 16 previously reported patients.
- Four patients achieved successful hematopoietic stem cell transplantation.
- The study reviews pathophysiology and treatment approaches, focusing on bone marrow transplantation.
Findings:
- Hematopoietic stem cell transplantation is a key treatment strategy.
- Challenges exist in transplanting into a diseased bone marrow niche.
- The study updates on five transplanted patients, including three previously reported and two new cases.
Implications:
- Understanding VPS45 mutations is crucial for diagnosing and treating this rare immune deficiency.
- Advances in hematopoietic stem cell transplantation may improve outcomes for affected individuals.
- Further research into overcoming challenges in bone marrow transplantation is warranted.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms
Point and Frameshift Mutations

